Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2026)

Catalyst Pharmaceuticals has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.53 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 12.71% year-over-year to 0.53; the trailing twelve-month figure through Mar 2026 stood at 0.53 (down 12.71% YoY), and the FY2025 full-year result was 0.6, down 19.05% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.53, down from 0.55 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.9 in Q4 2023, with the low at 0.53 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 0.65 across 5 years, with a median of 0.63 in 2022.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 49.16% — and 2024, when it sank 32.81%.
• Catalyst Pharmaceuticals' Asset Utilization Ratio stood at 0.6 in 2022, then surged by 49.16% to 0.9 in 2023, then slumped by 32.81% to 0.61 in 2024, then declined by 9.79% to 0.55 in 2025, then decreased by 2.97% to 0.53 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.53 (Q1 2026), 0.55 (Q4 2025), and 0.57 (Q3 2025), per Business Quant data.